Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ISEE

IVERIC bio (ISEE) Stock Price, News & Analysis

IVERIC bio logo

About IVERIC bio Stock (NASDAQ:ISEE)

Key Stats

Today's Range
$39.95
$39.95
50-Day Range
$36.90
$39.95
52-Week Range
$9.39
$39.99
Volume
N/A
Average Volume
3.62 million shs
Market Capitalization
$5.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ISEE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IVERIC bio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ISEE Stock News Headlines

Astellas Pharma Inc (ALPMY)
The End of Elon Musk…?
While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the verge of its biggest breakthrough yet — a revolutionary form of “Manifested AI” that Forbes has called a multi-trillion-dollar opportunity, potentially sparking a 25,000% growth market and setting up what he believes could be the greatest corporate comeback in history.tc pixel
Apellis adds safety warning to eye therapy
Astellas Completes Acquisition of Iveric Bio
B.Riley Financial Sticks to Its Hold Rating for IVERIC bio (ISEE)
See More Headlines

ISEE Stock Analysis - Frequently Asked Questions

IVERIC bio, Inc. (NASDAQ:ISEE) posted its quarterly earnings data on Wednesday, March, 1st. The company reported ($0.47) earnings per share for the quarter, missing analysts' consensus estimates of ($0.37) by $0.10.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that IVERIC bio investors own include Alibaba Group (BABA), Tesla (TSLA), Meta Platforms (META), NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
3/01/2023
Today
9/20/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:ISEE
CIK
1410939
Fax
N/A
Employees
163
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.76)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$185.21 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-57.00%
Return on Assets
-46.15%

Debt

Debt-to-Equity Ratio
0.20
Current Ratio
15.53
Quick Ratio
15.53

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.43 per share
Price / Book
9.02

Miscellaneous

Outstanding Shares
137,780,000
Free Float
134,063,000
Market Cap
$5.50 billion
Optionable
Optionable
Beta
1.06

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:ISEE) was last updated on 9/20/2025 by MarketBeat.com Staff
From Our Partners